Abstract
Purpose of Review
The aims of this report are to review literature supporting the use of Mohs micrographic surgery for treatment of non-melanoma skin cancer and to address indications and potential limitations of this form of therapy for non-melanoma skin cancer.
Recent Findings
The first randomized controlled trial comparing standard excision to Mohs micrographic surgery for treatment of facial basal cell carcinoma has recently been published, demonstrating a lower recurrence rate after Mohs surgery compared to standard excision after a 5-year and 10-year follow-up period, supporting its use in the treatment of high-risk basal cell skin cancer.
Summary
Mohs micrographic surgery is indicated for treatment of basal cell carcinomas and cutaneous squamous cell carcinomas at high risk of recurrence and for tumors located in areas where tissue conservation and/or functional preservation is desired.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol. 2015;151(10):1081–6. https://doi.org/10.1001/jamadermatol.2015.1187.
Kim C, Cheng J, Colegio OR. Cutaneous squamous cell carcinomas in solid organ transplant recipients: emerging strategies for surveillance, staging, and treatment. Semin Oncol. 2016;43(3):390–4. https://doi.org/10.1053/j.seminoncol.2016.02.019.
Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166(5):1069–80. https://doi.org/10.1111/j.1365-2133.2012.10830.x.
Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30(5 Pt 1):774–8.
Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975–83. https://doi.org/10.1056/NEJM200103293441306.
Chren MM, Sahay AP, Bertenthal DS, Sen S, Landefeld CS. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Investig Dermatol. 2007;127(6):1351–7. https://doi.org/10.1038/sj.jid.5700740.
Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989;15(3):315–28.
Mohs FE. Microscopically guided excision of cancer of the skin by means of chemosurgery. J Ark Med Soc. 1968;65(6):203–9.
Swanson NA. Mohs surgery. Technique, indications, applications, and the future. Arch Dermatol. 1983;119(9):761–73.
Shriner DL, McCoy DK, Goldberg DJ, Wagner RF Jr. Mohs micrographic surgery. J Am Acad Dermatol. 1998;39(1):79–97.
Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 1989;15(4):424–31.
Ad Hoc Task F, Connolly SM, Baker DR, Coldiron BM, Fazio MJ, Storrs PA, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012;67(4):531–50. https://doi.org/10.1016/j.jaad.2012.06.009.
• van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, et al. Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014;50(17):3011–20. https://doi.org/10.1016/j.ejca.2014.08.018. This was the first randomized controlled trial evaluating Mohs versus standard excision which demonstrated a significantly lower recurrence rate for high-risk facial basal cell carcinoma treated with Mohs micrographic surgery compared to standard excision after a 10-year follow-up period.
Muller FM, Dawe RS, Moseley H, Fleming CJ. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome. Dermatol Surg. 2009;35(9):1349–54. https://doi.org/10.1111/j.1524-4725.2009.01240.x.
Smeets NW, Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH, et al. Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet. 2004;364(9447):1766–72. https://doi.org/10.1016/S0140-6736(04)17399-6.
NCCN Clinical Practice Guidelines in Oncology: Basal Cell Skin Cancer. Version I.2018.
Mora RG, Robins P. Basal-cell carcinomas in the center of the face: special diagnostic, prognostic, and therapeutic considerations. J Dermatol Surg Oncol. 1978;4(4):315–21.
NCCN Clinical Practice Guidelines in Oncology: Squamous Cell Skin Cancer. Version 2. 2018.
Ebede TL, Lee EH, Dusza SW, Busam KJ, Nehal KS. Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers. Dermatol Surg. 2012;38(10):1631–8. https://doi.org/10.1111/j.1524-4725.2012.02570.x.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on HEAD & NECK: Non-melanoma Skin Cancer of the Head and Neck
Rights and permissions
About this article
Cite this article
Quintanilla-Dieck, J., Bichakjian, C.K. & Durham, A.B. Mohs Micrographic Surgery for Treatment of Non-melanoma Skin Cancer. Curr Otorhinolaryngol Rep 6, 115–119 (2018). https://doi.org/10.1007/s40136-018-0193-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40136-018-0193-5